Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis.
Seckinger A, Meissner T, Moreaux J, Goldschmidt H, Fuhler GM, Benner A, Hundemer M, Rème T, Shaughnessy JD Jr, Barlogie B, Bertsch U, Hillengass J, Ho AD, Pantesco V, Jauch A, De Vos J, Rossi JF, Möhler T, Klein B, Hose D. Seckinger A, et al. Among authors: hillengass j. Oncogene. 2009 Nov 5;28(44):3866-79. doi: 10.1038/onc.2009.257. Epub 2009 Aug 31. Oncogene. 2009. PMID: 19718049 Free PMC article.
Antiangiogenic therapy in hematologic malignancies.
Moehler TM, Hillengass J, Goldschmidt H, Ho AD. Moehler TM, et al. Among authors: hillengass j. Curr Pharm Des. 2004;10(11):1221-34. doi: 10.2174/1381612043452587. Curr Pharm Des. 2004. PMID: 15078137 Review.
Thalidomide in multiple myeloma.
Moehler TM, Hillengass J, Glasmacher A, Goldschmidt H. Moehler TM, et al. Among authors: hillengass j. Curr Pharm Biotechnol. 2006 Dec;7(6):431-40. doi: 10.2174/138920106779116919. Curr Pharm Biotechnol. 2006. PMID: 17168659 Review.
206 results